speb/financial-data huggingface dataset:
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 895172500000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 171559500000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 1679200000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 31375200000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 1175884969.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 60433400000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 63465200000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 417817100000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 236997500000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 68685100000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 55542800000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 597724000000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 13552000000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 91154400000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Payables: 228885100000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 1175884969.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 418957100000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 171559500000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 1817675800000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 943491200000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 804272500000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 476080500000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1341595300000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 1453643400000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 817903000000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 2946300000.00
ADANIENT.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -159659900000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 76677600000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 228484200000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 131159000000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 578300000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — EBIT: 19821100000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — EBITDA: 19821100000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 97325200000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 14065500000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 14065500000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -1708100000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income: 578300000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 578300000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 2323000000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: -36600000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 578300000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 614900000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 2286400000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -14065500000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -14065500000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 19821100000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 614900000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Operating Income: 20647600000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 228484200000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 6521200000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 69262800000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 5755600000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 131159000000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 5884400000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 207836600000.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
ADANIENT.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ADANIENT.NS income_statement (annual, 2025-03-31) — +Operating Expense: 223177300000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 83618000000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — +Total Revenue: 977110800000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 269658600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 225096000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 225096000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 96164700000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 96164700000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -113430000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -113430000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 143454600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 143454600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1801300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1801300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 185800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 185800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 57216100000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 57216100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 1180923454.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1200783885.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Basic EPS: 58.79
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 32.02
ADANIENT.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 23065500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 200811500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 200811500000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -298791400000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -298791400000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 155827600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 155827600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1154200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1154200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 31057800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 31057800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 68030800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 68030800000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -1482000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 10175500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 10175500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 20882300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 20882300000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -7673300000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -17166800000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -19442200000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Change In Payable: -29554700000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -14537300000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -88374300000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 2499500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1154200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1154200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 503139700000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 503139700000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 41683600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 357729600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 357729600000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 649502600000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 161304600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Current Assets: 409442200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 409442200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 13525000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 13525000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Current Debt: 112885800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 112885800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 126410800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 126410800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 473831500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 473831500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 2201600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 2201600000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Depreciation: 42113300000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 42113300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 78200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 78200000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 1180923454.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1200783885.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Diluted EPS: 58.79
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 32.02
ADANIENT.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 69423400000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 38449100000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 2900000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 2900000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 400000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — EBIT: 153663400000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — EBIT: 66850400000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — EBITDA: 195776700000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — EBITDA: 66850400000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 5492800000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — End Cash Position: 31057800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 41500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 41500000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 226553400000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 42552100000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 42552100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -253660400000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1723000000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: -47100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -1629500000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 13164400000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Goodwill: 10860500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 10860500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 285281500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 285281500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 97966000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 97966000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1152845600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1152845600000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Gross Profit: 327608200000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 108354000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 5488400000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 5488400000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Interest Expense: 48876000000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 14263100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 48876000000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 14263100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Interest Income: 13670400000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 13670400000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -55990100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 11840800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Inventory: 102873900000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 102873900000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1262038100000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1262038100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -269666100000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 2226000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 2226000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 57257600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 57257600000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 41683600000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 338544900000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 72412900000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 72412900000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 142302600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 142302600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 646012600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 646012600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 788315200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 788315200000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 338544900000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -99104300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 73970700000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 73970700000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 4885800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 4885800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 405883200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 405883200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 61564800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 61564800000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Minority Interests: -9059900000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -1699900000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -12815500000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 41683600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Net Debt: 727840600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 727840600000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 11224500000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income: 70990000000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income: 38449100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 69423400000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 38449100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 80179500000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 40149000000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: -129600000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 70990000000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 38449100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 71119600000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 38449100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 104614200000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 80049900000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 40149000000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Interest Income: -38933200000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -14263100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 50082100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 249088900000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 239440600000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -38933200000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -14263100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 7606400000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -6593200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1039415600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1039415600000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 3637400000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 9648300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 217858200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 217858200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Non Current Accrued Expenses: 10029400000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 10029400000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 69113300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 69113300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 2926600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2926600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 33623500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 33623500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 32280300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 32280300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 152081900000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 27393100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Normalized Income: 39803090490.65
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 8626733435.07
ADANIENT.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 45131000000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Operating Income: 104430900000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Operating Income: 24736000000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Operating Revenue: 977110800000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 269658600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 1190510909.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1190510909.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Inside Changein Cash: 481200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1039800000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1039800000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1154500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1154500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 38011200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 38011200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 274421000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 274421000000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -1363700000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 71823200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 71823200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 4808100000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4808100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 6380700000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 6357800000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 170154700000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 76050500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Payable: 70297300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 70297300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Properties: 9864200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 9864200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 58125200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 58125200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 36973000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 36973000000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Other Special Charges: -41644400000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: -39457300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 1566600000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Payables: 297346100000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Payables: 297346100000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 40779600000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 40779600000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Pretax Income: 104787400000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 52587300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Properties: 106144200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Properties: 106144200000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -12815500000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -6881600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 43393300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 43393300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 649502600000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 161304600000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 42113300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 569100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 569100000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -99104300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 36754000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 36754000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 251386900000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 251386900000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 56963700000.00
ADANIENT.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 3637400000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 8231300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 21395700000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Share Issued: 1190510909.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 1190510909.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Special Income Charges: 42022100000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 39457300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 503139700000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 503139700000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 217858200000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 217858200000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 12378290490.65
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 9634933435.07
ADANIENT.NS income_statement (annual, 2025-03-31) — Tax Provision: 29685200000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 12841100000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.28
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
ADANIENT.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -20947200000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1981355400000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1981355400000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 1149152300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1149152300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Debt: 914726000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 914726000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 564704500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 564704500000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Total Expenses: 872679900000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 244922600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1416650900000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1416650900000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 1571913400000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1571913400000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 942819400000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 942819400000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 3727600000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 1949900000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1949900000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 43694800000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 39457300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 43694800000.00
ADANIENT.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 39457300000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 3080000000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 3080000000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Work In Process: 16928500000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 16928500000.00
ADANIENT.NS balance_sheet (annual, 2025-03-31) — Working Capital: -64389300000.00
ADANIENT.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -64389300000.00
ADANIENT.NS income_statement (annual, 2025-03-31) — Write Off: -377700000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 79795800000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 219612000000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1258350573.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 5.84
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 119552800000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1258350573.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 5.84
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7344100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — EBIT: 29773900000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — EBITDA: 29773900000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 100059200000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 15111100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 15111100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -2420700000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income: 7344100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7344100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9764800000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7344100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7344100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 9764800000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -15111100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -15111100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 29773900000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 7344100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Operating Income: 20263400000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 219612000000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 4754200000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 70168100000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 14662800000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 119552800000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 5712500000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 199348600000.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
ADANIENT.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
ADANIENT.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1205053743.00
ADANIENT.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 26.54
ADANIENT.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1205053743.00
ADANIENT.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 26.54
ADANIENT.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1190510909.00
ADANIENT.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 1190510909.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 79315700000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 248195900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1202868747.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 46.78
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 146180900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1220082394.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 46.12
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 56270200000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — EBIT: 86900600000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — EBITDA: 86900600000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 102015000000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 17581300000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 17581300000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -995500000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income: 56270200000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 56270200000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 57265700000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 56270200000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 56270200000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 57265700000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -17581300000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -17581300000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 30579700000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 11365609714.47
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Operating Income: 22699300000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 248195900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 6558500000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 70374000000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: -56320900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 69319300000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 146180900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 56320900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 11416309714.47
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 14051100000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 225496600000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 56320900000.00
ADANIENT.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 56320900000.00
ADANIENT.NS income_statement (annual, 2026-03-31) — +Operating Expense: 177631700000.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 86533200000.00
ADANIENT.NS income_statement (annual, 2026-03-31) — +Total Revenue: 1002670200000.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 324393100000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 292304100000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 292304100000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 125426100000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 125426100000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -170438600000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -170438600000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 382512500000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 382512500000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1688000000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1688000000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 145200000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 145200000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 74059900000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 74059900000.00
ADANIENT.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 1220020156.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1290701754.00
ADANIENT.NS income_statement (annual, 2026-03-31) — Basic EPS: 75.66
ADANIENT.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -1.71
ADANIENT.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 31057800000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 391555900000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 391555900000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -333691200000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -333691200000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 199195800000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 199195800000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1292400000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1292400000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 62666700000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 62666700000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 100112300000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 100112300000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -1500400000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 32647800000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 32647800000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 30018900000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 30018900000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -83403600000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -30024300000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 2275700000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Change In Payable: 63353600000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -52990900000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -100789500000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 24033700000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1292400000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1292400000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 809259500000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 809259500000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 248539600000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 339091800000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 339091800000.00
ADANIENT.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 740660900000.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 221584900000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Current Assets: 611760400000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 611760400000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 19077900000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 19077900000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Current Debt: 105360600000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 105360600000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 124438500000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 124438500000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 589122500000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 589122500000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 2873800000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 2873800000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Depreciation: 61353400000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 61353400000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Derivative Product Liabilities: 100000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 100000.00
ADANIENT.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 1254378122.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1290701754.00
ADANIENT.NS income_statement (annual, 2026-03-31) — Diluted EPS: 73.59
ADANIENT.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.71
ADANIENT.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 92307400000.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2207100000.00
ADANIENT.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 2900000.00
ADANIENT.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 2900000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
ADANIENT.NS income_statement (annual, 2026-03-31) — EBIT: 199175700000.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — EBIT: 26343900000.00
ADANIENT.NS income_statement (annual, 2026-03-31) — EBITDA: 260529100000.00
ADANIENT.NS income_statement (quarterly, 2026-03-31) — EBITDA: 26343900000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 7575200000.00
ADANIENT.NS cash_flow (annual, 2026-03-31) — End Cash Position: 62666700000.00